Functional and Morphological Improvement of Dystrophic Muscle by Interleukin 6 Receptor Blockade
The anti-inflammatory agents glucocorticoids (GC) are the only available treatment for Duchenne muscular dystrophy (DMD). However, long-term GC treatment causes muscle atrophy and wasting. Thus, targeting specific mediator of inflammatory response may be more specific, more efficacious, and with few...
Main Authors: | Laura Pelosi, Maria Grazia Berardinelli, Loredana De Pasquale, Carmine Nicoletti, Adele D'Amico, Francesco Carvello, Gian Marco Moneta, Angela Catizone, Enrico Bertini, Fabrizio De Benedetti, Antonio Musarò |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-04-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396415000626 |
Similar Items
-
Increased Circulating Levels of Interleukin-6 Induce Perturbation in Redox-Regulated Signaling Cascades in Muscle of Dystrophic Mice
by: Laura Pelosi, et al.
Published: (2017-01-01) -
MicroRNAs modulated by local mIGF-1 expression in mdx dystrophic mice
by: Laura ePelosi, et al.
Published: (2015-05-01) -
Dystrophic muscle distribution in late-stage muscular dystrophy
by: Celeste Michelle Pilato, et al.
Published: (2021-08-01) -
The role of proto-oncogenes in normal and dystrophic skeletal muscle
by: Veal, Elizabeth Ann
Published: (1996) -
The activity and content of calpains in maturing dystrophic muscle membranes
by: Wang, Qiong
Published: (2014)